GIANT CELL GLIOBLASTOMA
Clinical trials for GIANT CELL GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for GIANT CELL GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer cell therapy trial for brain tumor withdrawn before starting
Disease control TerminatedThis study planned to test a new treatment combining CYNK-001 (natural killer cells from donated cord blood) with interleukin-2 in adults whose glioblastoma had returned and could be surgically removed. The goal was to see if this combination was safe and could extend the time be…
Matched conditions: GIANT CELL GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Celularity Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New brain cancer drug shows promise in early trial
Disease control TerminatedThis early-phase study tests whether adding a drug called S-Gboxin to standard treatment can help people with glioblastoma, a fast-growing brain cancer. The drug works by cutting off the energy supply to cancer cells. Ten patients with recurrent or progressive disease will receiv…
Matched conditions: GIANT CELL GLIOBLASTOMA
Phase: PHASE1 • Sponsor: Petrov, Andrey • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Experimental virus therapy for childhood brain tumors tested with radiation
Disease control TerminatedThis study aimed to test an experimental virus therapy called G207, combined with a single dose of radiation, in children whose high-grade glioma had come back after prior treatment. The virus was injected directly into the brain tumor to kill cancer cells and trigger an immune r…
Matched conditions: GIANT CELL GLIOBLASTOMA
Phase: PHASE2 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC